Conference item
Efficacy and safety of monotherapy with sirukumab, an anti-IL-6 cytokine monoclonal antibody, compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis: results of a global, randomized, double-blind, parallel-group, phase 3 study
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Arthritis and Rheumatology Journal website
- Volume:
- 68
- Issue:
- S10
- Article number:
- 3222
- Host title:
- Arthritis and Rheumatology
- Publication date:
- 2016-11-08
- DOI:
- EISSN:
-
2326-5205
- ISSN:
-
2326-5191
- Source identifiers:
-
820168
Item Description
- Pubs id:
-
pubs:820168
- UUID:
-
uuid:cf439929-e31a-4d22-97d8-940f2e8f64e2
- Local pid:
- pubs:820168
- Deposit date:
- 2018-05-21
Terms of use
- Copyright holder:
- © 2016, American College of Rheumatology
- Copyright date:
- 2016
If you are the owner of this record, you can report an update to it here: Report update to this record